Mergers & Acquisitions

Despite posting strong quarterly earnings, Adobe's stock continues to struggle, weighed down by investor apprehension over a formidable new competitor....

The final chapter for Tübingen-based mRNA pioneer CureVac on public markets is now written. A turbulent period in German stock...

Initial investor enthusiasm for Eutelsat’s strategic expansion has cooled, giving way to concerns over the financial implications of a massive...

Alphabet Inc. has cemented its position within the elite circle of companies boasting a market valuation exceeding $4 trillion, driven...

The world's largest net-lease REIT, Realty Income, is fundamentally reshaping its approach to capital. In a clear move to reduce...

Shares in French satellite operator Eutelsat soared by nearly 10% in a single trading session. The catalyst was a significant...

Alphabet Inc. has decisively countered early skepticism regarding its position in the artificial intelligence race. The company's recent entry into...

The final chapter has closed for CureVac as a publicly traded entity. The German biotech firm, once a beacon of...

Alphabet Inc. has emphatically cemented its position in the generative AI era with a single, transformative deal. The company, once...

The independent public trading story for CureVac has reached its conclusion. BioNTech's successful takeover has led to a suspension of...